-

Shareholder Alert: Robbins LLP Announces Northern Dynasty Minerals Ltd. (NAK) is Being Sued for Misleading Shareholders

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Northern Dynasty Minerals Ltd. (NYSE American: NAK) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities & Exchange Act of 1934 between December 21, 2017 and November 25, 2020. Northern Dynasty engages in the exploration of mineral properties in the U.S. Its principal mineral property is the Pebble copper-gold-molybdenum project comprising 2,402 mineral claims that covers approximately 417 square miles in southwest Alaska.

If you suffered a loss due to Northern Dynasty Minerals Ltd.'s misconduct, click here.

Northern Dynasty (NAK) Misled Shareholders About Approval for Pebble Project

According to the complaint, at the outset of the relevant period, Northern Dynasty announced that it was submitting a permit application to the U.S. Army Corps of Engineers for the Pebble Project. During the relevant period, Northern Dynasty provided updates on the Pebble Project, including its reduction in size, years of operation, and operational safeguards. However, Northern Dynasty failed to disclose that the Pebble Project was contrary to Clean Water Act guidelines and public interest, and was to extend for a longer duration and scope than conveyed to the public, and therefore, the permit application would be denied. Indeed, on August 24, 2020, the U.S. Army announced that it would not permit the Pebble Project as proposed under the Clean Water Act because "it would likely result in significant adverse effects on the aquatic system or human environment." The U.S. Army asked the Company to submit a mitigation plan in response to its finding. On this news, Northern Dynasty's stock declined almost 38% to close at $0.90 per share. On November 24, 2020, Northern Dynasty reported that the U.S. Army Corps of Engineers had rejected its permit applications relating to the Pebble Project. On this news, Northern Dynasty's stock fell close to 50% to close at $.40 per share on November 25, 2020.

If you purchased Northern Dynasty Minerals Ltd. (NAK) securities between December 21, 2017 and November 25, 2020, you have until February 2, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Northern Dynasty Minerals Ltd. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom